Live Analyst Rating Changes 24334 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Scott Fidel
GS

Scott Fidel

Goldman Sachs
Wall Street Analyst
★★★☆☆
#987
on 13Foresight · ranked by our own returns
65%
Success Rate
+7.7%
Average Return
36 of 55 calls profitable · +0.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 65% of Scott Fidel's ratings turned a profit when each position was held for 2 year — averaging +7.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

37 Buy 30 Hold 9 Sell
Scott's Stock Coverage 28 ratings · 2026-08-13
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return vs S&P 500 ⓘ
ARDT
Ardent Health Partners, Inc.
 Aug 10, 2026 HOLD Buy
+26.3% avg upside
16 analysts
$13.00
17.16% Upside
 +0.0% ·
ALHC
Alignment Healthcare
 Aug 02, 2026 BUY Strong Buy
+58.2% avg upside
19 analysts
$25.00
84.89% Upside
 -7.1% ·
CI
Cigna
 Aug 02, 2026 BUY Strong Buy
+25.4% avg upside
29 analysts
$352.00
26.86% Upside
 -0.4% ·
UHS
Universal Health
 Jul 30, 2026 HOLD Buy
+14.8% avg upside
22 analysts
$190.00
10.10% Upside
 +4.4% ·
HUM
Humana
 Jul 30, 2026 SELL Buy
+8.8% avg upside
34 analysts
$280.00
28.03% Downside
 -5.0% ·
THC
Tenet Healthcare
 Jul 29, 2026 BUY Strong Buy
-10.5% avg upside
27 analysts
$305.00
14.32% Upside
 +0.9% ·
HCA
HCA Healthcare
 Jul 27, 2026 BUY Buy
-1.1% avg upside
36 analysts
$485.00
16.96% Upside
 +5.7% ·
BTSG
BrightSpring Health Services, Inc.
 Jul 27, 2026 BUY Strong Buy
+10.3% avg upside
20 analysts
$80.00
33.95% Upside
 -15.7% ·
CVS
CVS Health
 Jul 27, 2026 BUY Strong Buy
+12.0% avg upside
39 analysts
$116.00
22.41% Upside
 -12.7% ·
MOH
Molina Healthcare
 Jul 23, 2026 HOLD Buy
+16.3% avg upside
26 analysts
$156.00
24.32% Downside
 +2.7% ·
UNH
UnitedHealth
 Jul 16, 2026 BUY Strong Buy
+12.5% avg upside
36 analysts
$490.00
20.82% Upside
 +0.6% ·
ELV
Elevance Health
 Jul 15, 2026 HOLD Strong Buy
+13.6% avg upside
33 analysts
$395.00
0.98% Downside
 +2.0% ·
CON
Concentra Group Holdings Parent, Inc.
 Jul 14, 2026 BUY Strong Buy
+11.5% avg upside
12 analysts
$34.00
1.62% Downside
 +13.6% ·
OPCH
Option Care Health
 Jun 08, 2026 HOLD Strong Buy
+23.0% avg upside
20 analysts
$22.00
7.79% Downside
 +19.4% ·
GMRS
GMR Solutions, Inc. Class A
 Jun 07, 2026 BUY Strong Buy
+52.6% avg upside
9 analysts
$35.00
172.26% Upside
 +18.9% ·
LFST
Lifestance Health Group
 Jun 05, 2026 HOLD Strong Buy
-5.5% avg upside
15 analysts
$9.00
26.49% Downside
 +64.9% ·
OSCR
Oscar Health
 May 11, 2026 HOLD Buy
-25.6% avg upside
16 analysts
$22.00
25.68% Downside
 +39.9% ·
CNC
Centene
 Apr 29, 2026 SELL Buy
+7.6% avg upside
29 analysts
$40.00
40.26% Downside
 -22.3% ·
ADUS
Addus Homecare
 Feb 26, 2025 BUY Strong Buy
+8.6% avg upside
18 analysts
$142.00
20.21% Upside
 +24.1% ·
ENSG
The Ensign Group
 Feb 07, 2025 BUY Strong Buy
-8.2% avg upside
9 analysts
$160.00
11.84% Downside
 +39.2% ·
PACS
PACS Group Inc
 Nov 18, 2024 BUY Strong Buy
+7.8% avg upside
9 analysts
$31.00
31.81% Downside
 +186.2% ·
AVAH
Aveanna Healthcare Holdings
 Nov 08, 2024 HOLD Buy
+1.6% avg upside
18 analysts
$5.50
39.24% Downside
 +54.4% ·
PNTG
Pennant Group
 Oct 07, 2024 BUY Strong Buy
-4.5% avg upside
9 analysts
$40.00
4.16% Upside
 +18.6% ·
EHC
Encompass Health
 Jul 24, 2024 BUY Strong Buy
-9.7% avg upside
22 analysts
$105.00
15.94% Downside
 +28.7% ·
ACHC
Acadia Healthcare
 Jan 05, 2024 BUY Strong Buy
+31.8% avg upside
17 analysts
$92.00
190.31% Upside
 -82.0% ·
WAL
Western Alliance
 Oct 25, 2021 BUY Strong Buy
+8.9% avg upside
27 analysts
$145.00
75.43% Upside
 -64.1% ·
CYH
Community Health
 Nov 11, 2016 SELL Sell
+43.2% avg upside
18 analysts
$4.25
46.09% Upside
 +22.2% ·
EHTH
Ehealth
 Jan 16, 2015 HOLD Hold
+1174.9% avg upside
19 analysts
$13.00
948.31% Upside
 +28.5% ·
🔒 23 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Scott Fidel — Frequently Asked Questions
How accurate are Scott Fidel's stock ratings?
Based on the calls 13Foresight could measure, about 62% of Scott's ratings were profitable over a one-year hold, with an average return of +3.4% per rating, or -1.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Scott ranked on 13Foresight?
Scott Fidel is currently ranked #987 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Scott cover?
Scott most recently has ratings on ARDT, ALHC, CI, UHS, HUM, THC, HCA, BTSG, CVS, MOH, UNH, ELV and 16 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.